Beetham Thomas W. sold VRDN
March 3, 2026 · Form 4 insider transaction
Beetham Thomas W. sold 3,138 shares of Viridian Therapeutics, Inc. at $29.32 per share, a transaction worth $92.0K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,138
Price
$29.32
Total value
$92.0K
InsiderBeetham Thomas W.
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 3, 2026
Filing dateMarch 4, 2026
Shares owned after13,271
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 1,000 shares acquired under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan (the "ESPP") on March 17, 2025 in transactions that were exempt under Rule 16b-3(c).